Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor-Reference-Cited by-同舟云学术

Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor

Published:2021 Issue:5 Volume:9 Page:1297-1314
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Xu Jingwen¹²³⁴^ORCID,Yan Xiangji⁵⁶⁷⁸⁴,Ge Xin⁹¹⁰¹¹¹²⁴,Zhang Mingzhen⁵⁶⁷⁸⁴^ORCID,Dang Xugang¹³¹⁴³⁴,Yang Yan¹²³⁴,Xu Feng¹⁵¹⁶¹⁷¹⁸⁴^ORCID,Luo Yanling¹⁵¹⁶¹⁷¹⁸⁴^ORCID,Li Guoliang¹²³⁴^ORCID

Affiliation:

1. School of Food and Biological Engineering

2. Shaanxi University of Science and Technology

3. Xi’an 710021

4. China

5. Institute of Medical Engineering

6. School of Basic Medical Sciences

7. Xi'an Jiaotong University

8. Xi'an

9. The First Affiliated Hospital of USTC

10. Division of Life Science and Medicine

11. University of Science and Technology of China

12. Hefei

13. College of Bioresources Chemical and Materials Engineering

14. Shaanxi University of Science & Technology

15. Key Laboratory of Macromolecular Science of Shaanxi Province

16. School of Chemistry and Chemical Engineering

17. Shaanxi Normal University

18. Xi’an 710062

Abstract

The PEG-based nanaovehicles with desired drug types and content were fabricated, it has profound significance in multidrug resistant tumors sustained treatments.

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Shaanxi University of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D0TB02192J

Reference68 articles.

1. Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer